Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:2183-2189

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, M.
Right arrow Articles by Bristow, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, M.
Right arrow Articles by Bristow, M. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1995;92:2183-2189.)
© 1995 American Heart Association, Inc.


Articles

Cardiac ß-Adrenergic Neuroeffector Systems in Acute Myocardial Dysfunction Related to Brain Injury

Evidence for Catecholamine-Mediated Myocardial Damage

Michel White, MD; Robert J. Wiechmann, MD; Robert L. Roden, MSc; Mary Beth Hagan, RN; Mary M. Wollmering, MD; J. David Port, PhD; Elizabeth Hammond, MD; William T. Abraham, MD; Eugene E. Wolfel, MD; JoAnn Lindenfeld, MD; David Fullerton, MD; Michael R. Bristow, MD, PhD

From the Cardiology and Cardiothoracic Surgery Divisions, University of Colorado Health Sciences Center, Denver, and the University of Utah School of Medicine, Salt Lake City.

Correspondence to Michael R. Bristow, MD, Division of Cardiology, University of Colorado Health Sciences Center, B-139, 4200 E 9th Ave, Denver, CO 80262.

Background Ten percent to 20% of potential cardiac donors with brain injury and no previous cardiac history have myocardial dysfunction. We assessed components of the ß-receptor–G-protein–adenylyl cyclase complex as well as the contractile response in 10 explanted acutely failing human hearts (donor heart dysfunction [DHD]) and compared the results with 13 age-matched nonfailing (NF) organ donor controls.

Methods and Results As measured by echocardiography, all DHD hearts exhibited a decreased shortening fraction (16±2%, mean±SEM). Although total and subpopulation ß-receptor densities measured by [125I]iodocyanopindolol (ICYP) were similar in the DHD and NF groups, DHD hearts exhibited a 30% decrease in maximum isoproterenol-stimulated adenylyl cyclase activity and a 50% decrease in the maximal response to zinterol. DHD hearts also exhibited decreases in adenylyl cyclase maximal stimulation by forskolin (211±25 [DHD] versus 295±23 [NF] pmol cAMP · min-1 · mg-1, P<.05) and 5'-guanylylimidodiphosphate (12.5±1.8 [DHD] versus 19.6±3.2 [NF] pmol cAMP · min-1 · mg-1, P<.05), but there was no significant decrease in adenylyl cyclase stimulation by Mn2+, a direct activator of adenylyl cyclase. Right ventricular trabeculae removed from DHD hearts exhibited a profound decrease in the contractile response to isoproterenol (8.7±1 [DHD] versus 22±2 [NF] mN, P<.001) as well as reduced calcium responses (7.2±1.6 [DHD] versus 14±3 [NF] mN, P=.03). Morphological examination of two hearts revealed some ultrastructural evidence suggestive of catecholamine-mediated injury, but there was no difference in tissue creatine kinase activity between the two groups.

Conclusions Compared with NF hearts, DHD hearts exhibit marked uncoupling of ß1- and ß2-adrenergic receptors from adenylyl cyclase and contractile response stimulation as well as decreased intrinsic systolic function. Thus, acute myocardial dysfunction accompanying brain injury is characterized by marked alterations in ß-adrenergic signal transduction as well as changes in the contractile apparatus, and this profile is markedly different from what occurs in the chronically failing human heart.


Key Words: heart failure • catecholamines • receptors • adrenergic • beta • proteins




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. K. Pandalai, K. M. McLean, C. F. Bulcao, J. Y. Duffy, K. M. D'Souza, W. H. Merrill, J. M. Pearl, and S. A. Akhter
Acute beta-blockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 792 - 798.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Liggett, J. Mialet-Perez, S. Thaneemit-Chen, S. A. Weber, S. M. Greene, D. Hodne, B. Nelson, J. Morrison, M. J. Domanski, L. E. Wagoner, et al.
A polymorphism within a conserved beta1-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure
PNAS, July 25, 2006; 103(30): 11288 - 11293.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Naidech, K. T. Kreiter, N. Janjua, N. D. Ostapkovich, A. Parra, C. Commichau, B.-F. M. Fitzsimmons, E. S. Connolly, and S. A. Mayer
Cardiac Troponin Elevation, Cardiovascular Morbidity, and Outcome After Subarachnoid Hemorrhage
Circulation, November 1, 2005; 112(18): 2851 - 2856.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. K. Pandalai, J. M. Lyons, J. Y. Duffy, K. M. McLean, C. J. Wagner, W. H. Merrill, J. M. Pearl, and S. A. Akhter
Role of the {beta}-adrenergic receptor kinase in myocardial dysfunction after brain death
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1183 - 1189.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J.-H. Park, S.-J. Kang, J.-K. Song, H. K. Kim, C. M. Lim, D.-H. Kang, and Y. Koh
Left Ventricular Apical Ballooning Due to Severe Physical Stress in Patients Admitted to the Medical ICU
Chest, July 1, 2005; 128(1): 296 - 302.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
S. R. R. Hall, L. Wang, B. Milne, and M. Hong
Central dexmedetomidine attenuates cardiac dysfunction in a rodent model of intracranial hypertension: [La dexmedetomidine centrale attenue la dysfonction cardiaque chez un modele rongeur d'hypertension intracranienne]
Can J Anesth, December 1, 2004; 51(10): 1025 - 1033.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
Y.J. Akashi, K. Nakazawa, M. Sakakibara, F. Miyake, H. Koike, and K. Sasaka
The clinical features of takotsubo cardiomyopathy
QJM, August 1, 2003; 96(8): 563 - 573.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. Bristow
{beta}-Adrenergic Receptors and Phosphodiesterase: Present and Future Perspectives
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 19 - 21.
[PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. d'Amati and F. S. Celi
Authors' Response: Expression of TR Isoforms in Failing Human Heart
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5089 - 5090.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Parekh, B. Venkatesh, D. Cross, A. Leditschke, J. Atherton, W. Miles, A. Winning, A. Clague, and C. Rickard
Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1328 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Rapenne, D. Moreau, F. Lenfant, V. Boggio, Y. Cottin, and M. Freysz
Could Heart Rate Variability Analysis Become an Early Predictor of Imminent Brain Death? A Pilot Study
Anesth. Analg., August 1, 2000; 91(2): 329 - 336.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
S. D. Kim and M. R. Piano
The Natriuretic Peptides: Physiology and Role in Left-Ventricular Dysfunction
Biol Res Nurs, July 1, 2000; 2(1): 15 - 29.
[Abstract] [PDF]


Home page
Biol Res NursHome page
S. D. Kim
Measurement of the Renin-Angiotensin System in Heart Failure
Biol Res Nurs, January 1, 2000; 1(3): 210 - 226.
[Abstract] [PDF]


Home page
CirculationHome page
A. M. Feldman and C. McTiernan
New Insight Into the Role of Enhanced Adrenergic Receptor-Effector Coupling in the Heart
Circulation, August 10, 1999; 100(6): 579 - 582.
[Full Text] [PDF]


Home page
CirculationHome page
V. J. Owen, P. B. J. Burton, M. C. Michel, O. Zolk, M. Bohm, J. R. Pepper, P. J. R. Barton, M. H. Yacoub, and S. E. Harding
Myocardial Dysfunction in Donor Hearts : A Possible Etiology
Circulation, May 18, 1999; 99(19): 2565 - 2570.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. Zolk, J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm
Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure
Circulation, April 27, 1999; 99(16): 2118 - 2123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. R. Zakhary, C. S. Moravec, R. W. Stewart, and M. Bond
Protein Kinase A (PKA)-Dependent Troponin-I Phosphorylation and PKA Regulatory Subunits Are Decreased in Human Dilated Cardiomyopathy
Circulation, February 2, 1999; 99(4): 505 - 510.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. T. Abraham
Pharmacologic Management of Chronic Heart Failure: A Review
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190.
[Abstract] [PDF]


Home page
CirculationHome page
M. R. Bristow, E. M. Gilbert, W. T. Abraham, K. F. Adams, M. B. Fowler, R. E. Hershberger, S. H. Kubo, K. A. Narahara, H. Ingersoll, S. Krueger, et al.
Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure
Circulation, December 1, 1996; 94(11): 2807 - 2816.
[Abstract] [Full Text]


Home page
CirculationHome page
E. J. Eichhorn and M. R. Bristow
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure
Circulation, November 1, 1996; 94(9): 2285 - 2296.
[Abstract] [Full Text]